| Catalog Number |
413400 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Patient Involvement (2645)
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
A customer in the united states notified biomérieux of false susceptible results for an escherichia coli survey strain when testing with the vitek® 2 ast-gn69 test kit.The customer obtained a susceptible result (mic=8) for ampicillin/sulbactam.The expected result for this survey strain is intermediate or resistant.The customer retested the strain and obtained mic=16 (intermediate), which is acceptable for this survey.As there is no patient associated with this quality control strain, there is no adverse event related to any patient's state of health.A biomérieux internal investigation will be initiated.
|
| |
|
Additional Manufacturer Narrative
|
|
A customer in the united states reported a false susceptible ampicillin/sulbactam result (mic=8) when they tested an escherichia coli api survey strain using vitek® 2ast-gn69 lot 5890743403.The expected result was resistant.Multiple requests for strain submittal from the customer have been unsuccessful.Submittal of the isolate is required in order to confirm a vitek 2 discrepancy compared to the reference method.Vitek 2 ast-gn69 lot # 5890743403 met final qc release criteria.This lot passed qc performance testing.
|
| |
|
Search Alerts/Recalls
|